Benitec Biopharma (BNTC) Operating Expenses (2019 - 2025)
Historic Operating Expenses for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to $9.8 million.
- Benitec Biopharma's Operating Expenses rose 7725.31% to $9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $41.8 million, marking a year-over-year increase of 8570.48%. This contributed to the annual value of $41.8 million for FY2025, which is 8570.48% up from last year.
- Per Benitec Biopharma's latest filing, its Operating Expenses stood at $9.8 million for Q2 2025, which was up 7725.31% from $15.3 million recorded in Q1 2025.
- Benitec Biopharma's 5-year Operating Expenses high stood at $15.3 million for Q1 2025, and its period low was $3.5 million during Q1 2022.
- For the 5-year period, Benitec Biopharma's Operating Expenses averaged around $6.1 million, with its median value being $4.8 million (2021).
- As far as peak fluctuations go, Benitec Biopharma's Operating Expenses crashed by 753.82% in 2022, and later soared by 27032.12% in 2025.
- Quarter analysis of 5 years shows Benitec Biopharma's Operating Expenses stood at $4.9 million in 2021, then increased by 15.72% to $5.6 million in 2022, then increased by 23.17% to $6.9 million in 2023, then surged by 55.98% to $10.8 million in 2024, then decreased by 8.99% to $9.8 million in 2025.
- Its Operating Expenses stands at $9.8 million for Q2 2025, versus $15.3 million for Q1 2025 and $10.8 million for Q4 2024.